Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target
Freek J H Sorgdrager, Petrus J W Naudé, Ido P Kema, Ellen A Nollen, Peter P De Deyn
Read Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target by Freek J H Sorgdrager, Petrus J W Naudé, Ido P Kema, Ellen A Nollen, Peter P De Deyn in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6833926.txt.
Description
Sorgdrager and co-authors review tryptophan metabolism and ageing, in Frontiers in Immunology. Ageing brings a slow, low-grade inflammation nicknamed inflammaging. It feeds many diseases of later life. Tryptophan, an amino acid from food, is broken down along the kynurenine pathway. That pathway helps calm immune responses and prevent overreaction.
Blood levels of tryptophan and kynurenine shift with age and in age-linked disease. The review explains how the pathway's products affect immune cells, gut microbes, and energy systems. Turning this pathway up or down can worsen or ease age-related illness in studies. The authors judge it both a useful marker and a possible drug target.
Catalog record
| CREATOR | Freek J H Sorgdrager, Petrus J W Naudé, Ido P Kema, Ellen A Nollen, Peter P De Deyn |
|---|---|
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |